134 related articles for article (PubMed ID: 24679400)
1. Effects of antidepressant medication on emotion regulation in depressed patients: an iSPOT-D report.
McRae K; Rekshan W; Williams LM; Cooper N; Gross JJ
J Affect Disord; 2014 Apr; 159():127-32. PubMed ID: 24679400
[TBL] [Abstract][Full Text] [Related]
2. International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.
Williams LM; Rush AJ; Koslow SH; Wisniewski SR; Cooper NJ; Nemeroff CB; Schatzberg AF; Gordon E
Trials; 2011 Jan; 12():4. PubMed ID: 21208417
[TBL] [Abstract][Full Text] [Related]
3. Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial.
Arnow BA; Blasey C; Williams LM; Palmer DM; Rekshan W; Schatzberg AF; Etkin A; Kulkarni J; Luther JF; Rush AJ
Am J Psychiatry; 2015 Aug; 172(8):743-50. PubMed ID: 25815419
[TBL] [Abstract][Full Text] [Related]
4. Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study.
Shilyansky C; Williams LM; Gyurak A; Harris A; Usherwood T; Etkin A
Lancet Psychiatry; 2016 May; 3(5):425-35. PubMed ID: 26995298
[TBL] [Abstract][Full Text] [Related]
5. Impairment and distress patterns distinguishing the melancholic depression subtype: an iSPOT-D report.
Day CV; John Rush A; Harris AW; Boyce PM; Rekshan W; Etkin A; DeBattista C; Schatzberg AF; Arnow BA; Williams LM
J Affect Disord; 2015 Mar; 174():493-502. PubMed ID: 25554994
[TBL] [Abstract][Full Text] [Related]
6. Brain imaging predictors and the international study to predict optimized treatment for depression: study protocol for a randomized controlled trial.
Grieve SM; Korgaonkar MS; Etkin A; Harris A; Koslow SH; Wisniewski S; Schatzberg AF; Nemeroff CB; Gordon E; Williams LM
Trials; 2013 Jul; 14():224. PubMed ID: 23866851
[TBL] [Abstract][Full Text] [Related]
7. Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT-D Trial.
Williams LM; Korgaonkar MS; Song YC; Paton R; Eagles S; Goldstein-Piekarski A; Grieve SM; Harris AW; Usherwood T; Etkin A
Neuropsychopharmacology; 2015 Sep; 40(10):2398-408. PubMed ID: 25824424
[TBL] [Abstract][Full Text] [Related]
8. ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial.
Schatzberg AF; DeBattista C; Lazzeroni LC; Etkin A; Murphy GM; Williams LM
Am J Psychiatry; 2015 Aug; 172(8):751-9. PubMed ID: 25815420
[TBL] [Abstract][Full Text] [Related]
9. A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial.
Etkin A; Patenaude B; Song YJ; Usherwood T; Rekshan W; Schatzberg AF; Rush AJ; Williams LM
Neuropsychopharmacology; 2015 May; 40(6):1332-42. PubMed ID: 25547711
[TBL] [Abstract][Full Text] [Related]
10. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.
Matrisciano F; Bonaccorso S; Ricciardi A; Scaccianoce S; Panaccione I; Wang L; Ruberto A; Tatarelli R; Nicoletti F; Girardi P; Shelton RC
J Psychiatr Res; 2009 Jan; 43(3):247-54. PubMed ID: 18511076
[TBL] [Abstract][Full Text] [Related]
11. Prediction of nonremission to antidepressant therapy using diffusion tensor imaging.
Grieve SM; Korgaonkar MS; Gordon E; Williams LM; Rush AJ
J Clin Psychiatry; 2016 Apr; 77(4):e436-43. PubMed ID: 27137427
[TBL] [Abstract][Full Text] [Related]
12. Normalization of EEG in depression after antidepressant treatment with sertraline? A preliminary report.
van der Vinne N; Vollebregt MA; Boutros NN; Fallahpour K; van Putten MJAM; Arns M
J Affect Disord; 2019 Dec; 259():67-72. PubMed ID: 31437703
[TBL] [Abstract][Full Text] [Related]
13. Utility of event-related potentials in predicting antidepressant treatment response: An iSPOT-D report.
van Dinteren R; Arns M; Kenemans L; Jongsma ML; Kessels RP; Fitzgerald P; Fallahpour K; Debattista C; Gordon E; Williams LM
Eur Neuropsychopharmacol; 2015 Nov; 25(11):1981-90. PubMed ID: 26282359
[TBL] [Abstract][Full Text] [Related]
14. Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression.
Gyurak A; Patenaude B; Korgaonkar MS; Grieve SM; Williams LM; Etkin A
Biol Psychiatry; 2016 Feb; 79(4):274-81. PubMed ID: 25891220
[TBL] [Abstract][Full Text] [Related]
15. Increased hippocampal tail volume predicts depression status and remission to anti-depressant medications in major depression.
Maller JJ; Broadhouse K; Rush AJ; Gordon E; Koslow S; Grieve SM
Mol Psychiatry; 2018 Aug; 23(8):1737-1744. PubMed ID: 29133948
[TBL] [Abstract][Full Text] [Related]
16. The international Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment.
Saveanu R; Etkin A; Duchemin AM; Goldstein-Piekarski A; Gyurak A; Debattista C; Schatzberg AF; Sood S; Day CV; Palmer DM; Rekshan WR; Gordon E; Rush AJ; Williams LM
J Psychiatr Res; 2015 Feb; 61():1-12. PubMed ID: 25586212
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein.
O'Connell CP; Goldstein-Piekarski AN; Nemeroff CB; Schatzberg AF; Debattista C; Carrillo-Roa T; Binder EB; Dunlop BW; Craighead WE; Mayberg HS; Williams LM
Am J Psychiatry; 2018 Mar; 175(3):251-261. PubMed ID: 29241359
[TBL] [Abstract][Full Text] [Related]
18. Clinically Useful Genetic Markers of Antidepressant Response: How Do We Get There From Here?
McMahon FJ
Am J Psychiatry; 2015 Aug; 172(8):697-9. PubMed ID: 26234589
[No Abstract] [Full Text] [Related]
19. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
Zisook S; Lesser IM; Lebowitz B; Rush AJ; Kallenberg G; Wisniewski SR; Nierenberg AA; Fava M; Luther JF; Morris DW; Trivedi MH
J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant switching among adherent patients treated for depression.
Marcus SC; Hassan M; Olfson M
Psychiatr Serv; 2009 May; 60(5):617-23. PubMed ID: 19411348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
